Lv4
608 积分 2023-02-19 加入
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial
14小时前
已完结
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
24天前
已完结
Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial
1个月前
已完结
The pharmacogenomic and immune landscape of snoRNAs in human cancers
2个月前
已完结
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation
2个月前
已完结
Severe Refractory Checkpoint Inhibitor‐Related Hepatitis Reversed With Anti‐Thymocyte Globulin and n‐Acetylcysteine
2个月前
已完结
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?
2个月前
已完结
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor–Related Cholangiohepatitis
2个月前
已完结
Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma
2个月前
已完结
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
2个月前
已完结
皖公网安备34019202002308
